Drug safety: COVID-19 complicates already challenged FDA foreign inspection program : testimony before the Committee on Finance, U.S. Senate /

Bibliographic Details
Main Author:	Denigan-Macauley, Mary (Author)
Corporate Authors:	United States. Government Accountability Office (Author), United States. Congress. Senate. Committee on Finance (sponsoring body.)
Format:	Government Document eBook
Language:	English
Published:	[Washington, D.C.] : United States Government Accountability Office, 2020.
Series:	Testimony ; GAO-2-626T.
Subjects:	United States. > Food and Drug Administration > Rules and practice. COVID-19 (Disease) > Treatment > United States. Drugs > Inspection > United States. Drugs > United States > Safety measures > Evaluation. Pharmaceutical industry > Quality control > Evaluation. Drugs > Safety regulations > United States > Evaluation. Drug reimportation > United States > Evaluation. Imports > United States > Safety measures > Evaluation.
Online Access:	https://purl.fdlp.gov/GPO/gpo139201

Description
Item Description:	"For release on delivery, expected at 2:30 p.m. ET, Tuesday, June 2, 2020."
Physical Description:	1 online resource (26 pages) : color illustrations, color maps.
Bibliography:	Includes bibliographical references.